國家藥監局註銷默沙東甲肝疫苗；北京市疫苗檢驗中心預計年底投用；華西造全球首款乙肝mRNA疫苗獲FDA臨床許可

疫苗圈

2025/10/17

今日要聞(2025.10.17）國家藥監局註銷默沙東甲肝疫苗首款國產九價HPV疫苗在廣東正式開打「華西造」全球首個乙肝病毒mRNA疫苗獲美國FDA臨床試驗許可北京市疫苗檢驗中心預計年底投用，多項藥械監管改革同步推進山東修訂疫苗流通監督辦法2026年1月實施強化全鏈條監管科興四價流感疫苗完成菲律賓孕婦人群IV期臨床首例入組斯帕坦堡縣為應對麻疹疫情提供免費MMR疫苗官方發布國家藥監局註銷默沙東甲肝疫苗...

網頁鏈接

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2576097565"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2576097565\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2576097565?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-10-17 17:44","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2576097565","market":"us","top_or_hot":-1,"title":"國家藥監局註銷默沙東甲肝疫苗；北京市疫苗檢驗中心預計年底投用；華西造全球首款乙肝mRNA疫苗獲FDA臨床許可","media":"疫苗圈","content":"<div>\n<p>今日要聞(2025.10.17）國家藥監局註銷默沙東甲肝疫苗首款國產九價HPV疫苗在廣東正式開打「華西造」全球首個乙肝病毒mRNA疫苗獲美國FDA臨床試驗許可北京市疫苗檢驗中心預計年底投用，多項藥械監管改革同步推進山東修訂疫苗流通監督辦法2026年1月實施強化全鏈條監管科興四價流感疫苗完成菲律賓孕婦人群IV期臨床首例入組斯帕坦堡縣為應對麻疹疫情提供免費MMR疫苗官方發布國家藥監局註銷默沙東甲肝疫苗...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017184023a464fc79&s=b\">網頁鏈接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>國家藥監局註銷默沙東甲肝疫苗；北京市疫苗檢驗中心預計年底投用；華西造全球首款乙肝mRNA疫苗獲FDA臨床許可</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n國家藥監局註銷默沙東甲肝疫苗；北京市疫苗檢驗中心預計年底投用；華西造全球首款乙肝mRNA疫苗獲FDA臨床許可\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">疫苗圈</strong><span class=\"h-time small\">2025-10-17 17:44</span>\n</p>\n</h4>\n</header>\n<article>\n<div>\n<p>今日要聞(2025.10.17）國家藥監局註銷默沙東甲肝疫苗首款國產九價HPV疫苗在廣東正式開打「華西造」全球首個乙肝病毒mRNA疫苗獲美國FDA臨床試驗許可北京市疫苗檢驗中心預計年底投用，多項藥械監管改革同步推進山東修訂疫苗流通監督辦法2026年1月實施強化全鏈條監管科興四價流感疫苗完成菲律賓孕婦人群IV期臨床首例入組斯帕坦堡縣為應對麻疹疫情提供免費MMR疫苗官方發布國家藥監局註銷默沙東甲肝疫苗...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017184023a464fc79&s=b\">網頁鏈接</a>\n\n</div>\n\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017184023a464fc79&s=b\">疫苗圈</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1934455863.HKD","symbol_name":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"A\" (HKD) ACC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017184023a464fc79&s=b","article_id":"2576097565","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017184023a464fc79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2576097565","pubTimestamp":1760694299,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"研究顯示，國產甲肝疫苗免疫效果、安全性不劣於進口款。來源：中新網「華西造」全球首個乙肝病毒mRNA疫苗獲美國FDA臨床試驗許可近日，成都威斯津生物醫藥自主研發的全球首個乙肝病毒相關肝癌 mRNA 疫苗WGc-0201，獲美國FDA臨床試驗許可。全國首個疫苗檢驗單體項目北京市疫苗檢驗中心，預計年底投入使用，未來可滿足年 4000批次疫苗批簽發檢驗需求。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1934455863.HKD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"A\" (HKD) ACC","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU2461242641.AUD":"WELLINGTON US QUALITY GROWTH \"A\" (AUDHDG) ACC","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","SG9999014542.SGD":"United Income Focus Trust Acc SGD","IE00BN8TJ469.HKD":"FTGF CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A\" (HKD) INC","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","BK4534":"瑞士信贷持仓","LU1116320737.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (USD) INC","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","LU1929549753.HKD":"FRANKLIN INCOME \"A\" (HKD) INC","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU1116320901.HKD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (HKD) INC","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","BK4533":"AQR资本管理(全球第二大对冲基金)","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","LU0965509010.AUD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (AUDHDG) INC","BK4516":"特朗普概念","SG9999014559.SGD":"United Income Focus Trust Dis SGD","MRK":"默沙东","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU1066051225.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AC\" (USD) ACC","LU0203345920.USD":"SCHRODER ISF QEP GLB ACT. VL \"A\" (USD) ACC","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","SG9999001176.USD":"United Global Healthcare Acc USD","LU0006306889.USD":"SCHRODER ISF US LARGE CAP \"A\" (USD) INC AV","LU1037948897.HKD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (HKD) INC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU1069347547.HKD":"AB SICAV I - GLOBAL VALUE PORTFOLIO \"AD\" (HKD) INC","BK4588":"碎股","BK4550":"红杉资本持仓","LU2023250843.SGD":"Allianz Thematica Cl AT Acc H2-SGD","LU0265550359.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A2\" (USD) ACC","LU1934455277.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"AD\" (USD) INC","LU1941712264.USD":"ALLIANZ PET AND ANIMAL WELLBEING \"A\" (USD) INC","LU0985320562.USD":"NORDEA 1 GLOBAL STARS EQUITY \"BP\" (USD) ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU0320765646.SGD":"FTIF - Franklin Income A MDIS SGD-H1","LU0265550946.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A5\" (USD) INC"},"translate_title":"The State Food and Drug Administration canceled Merck's hepatitis A vaccine; Beijing Vaccine Inspection Center is expected to be put into use by the end of the year; West China manufactures the world's first hepatitis B mRNA vaccine and obtains FDA clinical approval","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRK":1.5},"content_text":"今日要聞(2025.10.17）國家藥監局註銷默沙東甲肝疫苗首款國產九價HPV疫苗在廣東正式開打「華西造」全球首個乙肝病毒mRNA疫苗獲美國FDA臨床試驗許可北京市疫苗檢驗中心預計年底投用，多項藥械監管改革同步推進山東修訂疫苗流通監督辦法2026年1月實施強化全鏈條監管科興四價流感疫苗完成菲律賓孕婦人群IV期臨床首例入組斯帕坦堡縣為應對麻疹疫情提供免費MMR疫苗官方發布國家藥監局註銷默沙東甲肝疫苗2025年10月15日，國家藥監局註銷默沙東甲型肝炎滅活疫苗，此前國內有6家甲肝疫苗企業，默沙東是唯一外資。針對已接種其首針的孩子，按相關説明，可換其他廠家同種滅活疫苗，或間隔≥6個月接種1劑甲肝減毒活疫苗。研究顯示，國產甲肝疫苗免疫效果、安全性不劣於進口款。來源：國家藥監局首款國產九價HPV疫苗在廣東正式開打2025年10月16日，廣東省完成首批國產九價 HPV 疫苗接種，標誌該疫苗正式落地廣東，為 9-45 歲女性新增選擇。此疫苗今年5月獲批上市，中國成全球第二個能獨立供應高價次 HPV 疫苗的國家。其9-17歲女性兩劑次全程1040元，18-45歲女性三劑次1560元。三期臨床顯示，其預防7種高危型 HPV 持續感染保護效力100%，與進口九價效果相當，可預防9種 HPV 亞型，比二價預防範圍更廣。來源：中新網「華西造」全球首個乙肝病毒mRNA疫苗獲美國FDA臨床試驗許可近日，成都威斯津生物醫藥（依託華西醫院實驗室）自主研發的全球首個乙肝病毒相關肝癌 mRNA 疫苗WGc-0201，獲美國FDA臨床試驗許可。肝癌致死率高，超 60%與乙肝相關，現有療法效果差、副作用大。該疫苗用自研mRNA技術與LNP遞送系統，可激活雙重免疫，打破免疫耐受，此前國內試驗已驗證安全性。團隊還牽頭國家專項，有多項 mRNA 藥物進入臨床，佈局85項國際專利，未來有望突破全球mRNA腫瘤疫苗空白，助力我國生物醫藥發展。來源：四川觀察北京市疫苗檢驗中心預計年底投用，多項藥械監管改革同步推進2025年10月16日，北京召開相關發布會，披露多項藥械監管改革舉措。全國首個疫苗檢驗單體項目北京市疫苗檢驗中心，預計年底投入使用，未來可滿足年 4000批次疫苗批簽發檢驗需求。同時，北京推進6項突破性改革，如罕見病藥品 「北京模式」、創新藥臨床試驗審批縮至30工作日；國談藥 「雙通道」 機制覆蓋 570種藥，今年51個創新藥快速掛網，還簡化創新藥械入院流程，加速其臨床應用，助力醫藥產業高質量發展。來源：網絡山東修訂疫苗流通監督辦法2026年1月實施強化全鏈條監管2025年10月，山東省藥監局印發新修訂《山東省疫苗流通質量監督檢查辦法》，2026年1月1日起實施，共6章29條，適用於省內疫苗配送單位、疾控機構及接種單位的質量監督檢查。辦法明確各方主體責任，要求遵守疫苗儲運規範；新增疫苗委託配送規定，疾控機構需評估配送單位能力並報告，受託企業不得再委託；細化冷鏈要求，配送單位需配兩個以上獨立冷庫，疾控與接種單位設備需達標且定期校對；還新增追溯管理，要求記錄相關信息並上傳平台，實現冷鏈物流與流向 「雙追溯」。來源：山東省藥監局企業動態科興四價流感疫苗完成菲律賓孕婦人群IV期臨床首例入組2025年10月13日，科興四價流感病毒裂解疫苗在菲律賓開展的孕婦人群免疫原性和安全性 IV 期臨床研究完成首例入組。該研究為隨機雙盲陽性對照設計，計劃招募150名 20-32 孕周的18-39歲孕婦，按2:1分組接種科興疫苗或同類產品，將監測至分娩後56天安全性，並評估免疫原性及母傳抗體。科興流感疫苗全球累計接種超1億人次，2025年智利全用其疫苗且孕婦接種率近80%。孕婦屬流感重症高危人群，接種可護自身並傳抗體給胎兒，科興此疫苗已擴齡至 6 月齡以上，該研究將補充其孕婦群體循證證據。來源：SINOVAC科興","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}